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Background: A Chinese herbal formula, Yi-Qi-Fu-Sheng (YQFS), has long been employed clinically to treat cancer
patients. We aimed to determine its effectiveness as a treatment method for colorectal cancer. We investigated the
therapeutic effects of YQFS on colorectal cancer, as well as the underlying mechanisms, which have not previously
been explored.
Methods: First, YQFS was extracted and chemically characterized. We then tested the effects of YQFS on
proliferation and migration by MTT and transwell migration assays in vitro. Mouse xenograft models of colorectal
cancer were established by inoculation with HCT-116 cells, and mice received one of three oral doses (200, 400 and
800 mg/kg/day) to evaluate the effects of YQFS extract. Metalloproteinase-2/9 (MMP-2/9) expression in mice was
evaluated by gelatin zymography assay. Apoptosis was evaluated by flow cytometry (FCM) analysis in vitro and by
TUNEL assay in vivo. ERK and p-ERK expression were evaluated by western blot analysis at the protein level in vitro,
and by quantitative RT-PCR at mRNA level in vivo.
Results: Our results show that YQFS significantly inhibits colorectal cancer cell proliferation and induces apoptosis
and cell cycle arrest at the G1− and S-phase in HCT-116 cells. Furthermore, YQFS effectively retards tumor cell
migration and invasion by inhibiting metalloproteinase-2/9 (MMP-2/9) expression, both in vitro and in vivo.
Moreover, YQFS had an inhibitory effect on tumor growth in vivo, and induced apoptosis through the inhibition of
the ERK1/2 pathway both in vitro and in vivo.
Conclusion: These findings demonstrate that YQFS extract has an anti-tumor effect in colorectal cancer, which
could be attributed to ERK1/2-dependent inhibition of MMP-2/9 expression.
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Yi-Qi-Fu-Sheng herbal formulaBackground
Colorectal cancer has an incidence of approximately
150,000 per year in the United States and is the third
leading cause of cancer-related deaths in both men
and women [1]. Although surgery, chemotherapy and
radiotherapy have been the mainstay of colorectal* Correspondence: luming_@sohu.com; dengwanwan7723@sina.com
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reproduction in any medium, provided the orcancer treatment, traditional Chinese medicine (TCM)
has the advantage of reducing cancer therapy-induced
toxicity and is a popular form of complementary and
alternative medicine (CAM) in China [2]. In recent
years, with increased popularity with patients in China,
the modified classic formula has been shown to fur-
ther minimize the side effects of surgery, radiation and
chemotherapy [3], increase immune function [4] and
improve survival [5].
Mitogen-activated protein kinases (MAPK), which be-
long to a large family of serine-threonine kinases, formtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cell surface to the nucleus [6]. The ERK/MAPK pathway
is one of the most important pathways for cell prolifera-
tion, and several key growth factors and proto-
oncogenes transduce signals that promote growth and
differentiation through this cascade [7]. Several lines of
evidence suggest that the ERK/MAPK pathway, but not
the JNK pathway or the p38 MAPK pathway, is a major
regulator of cell proliferation in colorectal cancer [8].
During oncogenic transformation, colorectal cancer cells
escape normal growth and differentiation control mech-
anisms and acquire the ability to invade surrounding tis-
sues and organs. Activation of ERK1/2 culminates in the
phosphorylation of transcription factors that regulate
specific genes to increase cell proliferation and inhibit
apoptosis [9].
Traditional Chinese prescriptions and formulae,
which are based on TCM principles, have been identi-
fied as effective anti-cancer drugs in for example breast
carcinoma [10], gastric cancer [11] and colorectal can-
cer [12]. YQFS, a Chinese herbal formula, is composed
of six herbs: Dang-shen (Codonopsis pilosula), Bai-zhu
(Atractylodes macrocephala), Fu-Ling (Poria), Gan-cao
(Radix Glycytthizae), Rou-dou-kou (Myristica fragrans)
and Ba-yue-zha (Fiveleaf Akebia fruit), in a ratio of
4:3:4:3:3:3. The components of the herbal formula are
mostly derived from the classic formula “Si-Jun-Zi
Tang” in TCM, which has a long history in treating de-
ficiencies of the spleen and qi in cancer patients.
Recent clinical studies suggest that Si-Jun-Zi Tang
herbal formula possesses anti-tumor and immune en-
hancing properties in colorectal cancer [13]. Modifica-
tion of the Si-Jun-Zi Tang formula has been shown to
have a wide range of immunopotentiating effects. As an
example, administering two drugs, Rou-dou-kou and
Ba-yue-zha, found in the Si-Jun-Zi Tang formula,
exhibited anti-cancer effects and provided an advantage
above using chemotherapy alone [14-16].
Although the anti-cancer effects of YQFS herbal for-
mula have previously been demonstrated, the underlying
mechanisms, in colorectal cancer, remain unknown. In
this study, our objective was to elucidate the effect and
the molecular mechanism(s) of the Chinese herbal for-
mula, YQFS, in colorectal cancer cells.
Methods
Cell culture and reagents
Human colorectal cancer HCT-116 cells were obtained
from the cell bank of the Chinese Academy of Sci-
ences (CAS) and maintained in RPMI 1640 medium
supplemented with 10% (v/v) heat-inactivated fetal calf
serum, 2 mM glutamine, 100 units/ml penicillin, and
100 μg/ml streptomycin (Invitrogen, Carlsbad, CA) at
37°C in a 5% CO2 humidified atmosphere.Preparation of YQFS
All crude drugs (defined as a dried, unprocessed plant,
and referring to one that was or is an official drug plant or
the source of a refined drug substance) of YQFS were pur-
chased from a local herbal medicine market (Xinjiang,
China). All components were deposited at the herbarium
located in the College of Pharmacy, Xinjiang Medical Uni-
versity. Briefly, Dang-shen, Bai-zhu, Fu-Ling, Gan-cao,
Rou-dou-kou and Ba-yue-zha were mixed at a ratio of
4:3:4:3:3:3. YQFS extracts were prepared according to a
previously validated method [17]. The mixture (300 g) was
homogenized to a fine powder and then extracted twice in
a reflux condenser for 2 h with 75% ethanol in a heated
water-bath. The pooled extract was filtered to remove
debris, and the ethanol was removed by rotary evapor-
ation under reduced pressure. The concentrated extract
was then dried by lyophilization to obtain the YQFS ex-
tract at a yield of 190 g. According to HPLC analysis of
the YQFS extract, the ratio of crude drug to ethanol ex-
tract was 1 g/0.633 g. The extract was stored at 4°C,
dissolved in distilled water and diluted with physiologic
saline for the animal tests.
MTT cell viability assays
Drug sensitivity was determined using the MTT assay.
Briefly, cells were trypsinized and plated out into 96 well
plates at a density of 3 × 103 cells per well. Cells were
cultured overnight and re-fed with fresh medium at vari-
ous concentrations of YQFS for 24 h. Thereafter, 50 μl
3-(4,4-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (Sigma-Aldrich, St. Louis, MO) in PBS
was added to each well, incubated for 4 h at 37°C and
the formazan crystals that formed were dissolved in
150 μl dimethyl sulfoxide. The optical density was
recorded at 570 nm on a microplate reader (Bio-Rad,
Hercules, CA).
Apoptosis assays
Apoptosis assay in vitro
Cells were seeded in 6-well plates (4 × 105/well). After
24 h, three dose concentrations of YQFS (obtained from
the result of YQFS IC10 in the MTT assay) were added.
Flow cytometry was used to detect apoptosis by deter-
mining the relative amount of Annexin V-FITC-positive-
PI-negative cells, as previously described. Unstained
cells, cells stained with Annexin V-FITC alone, and cells
stained with propidium iodide alone were used as con-
trols. Singly stained cells were used to adjust electronic
compensation on FL1 and FL2 channels.
Apoptosis assay in vivo
Dual staining for a-SMA and TUNEL was undertaken in
representative liver sections to localize apoptotic hepatic
stellate cells (HSCs). The sections were blocked with
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mary antibody for a-SMA, in a dilution of 1:1000, was
added and incubated for 30 min at room temperature.
Histofine labeled polymer (Nichirei, Tokyo, Japan) was
added for 20 min at room temperature. The sections were
then incubated with the substrate chromogen nitro-blue
tetrazolium (NBT) for 5 min. The number of apoptotic
HSCs were counted by viewing specimens under the
microscope. The apoptosis index was defined as the num-
ber of apoptotic cells in every hundred cells counted.
Wound healing assay
Migration assays were performed following a standard
protocol wound repair assay [18]. Briefly, cells were cul-
tured in standard conditions, as described above, to
70%-80% confluency after treatment with YQFS. The
monolayers were incubated and wounded in a line
across the well with a standard pipette tip. The wounded
monolayers were washed twice with phosphate-buffered
saline (PBS) and incubated with serum-containing
medium. The rate of wound closure was measured and
photographed over 24 h. This allows imaging of both
wound edges using the 10× objective.
Western blot analysis
Whole cell lysate for SDS-PAGE and western blot analysis
for ERK expression was prepared as previously reported
[19]. To prepare the lysates from dissected in vivo tumors,
samples were snap frozen in liquid nitrogen immediately
after sacrificing the animals and stored at −80°C. The lysate
was incubated on ice in immunoprecipitation assay buffer
for 2 h before being homogenized using a mortar and pestle.
The homogenized sample was centrifuged and the super-
natant was collected and stored at −80°C. Protein quantifica-
tion and western blotting for ERK were done as previously
reported [19]. Equal loading was confirmed with β-actin
(0.1 μg/mL, Sigma Chemical). Densitometric analysis was
done using Scion Imaging software (Scion Corporation),
using total ERK or β-actin as a control for each sample.
Animals
Tumor xenograft animal model Male athymic nude
mice (NCr-nu) were purchased from Sino-British
SIPPR/BK lab Animal Ltd., Co (Shanghai, China, license
No. SCXK 2010–0002) and maintained under specific
pathogen-free conditions for the studies. All animal pro-
tocols were approved by the Institutional Animal Use
and Care Committee. All experiments and animal care
protocols were approved by the Shanghai Medical Ex-
perimental Animal Care Commission in accordance with
the Provision and General Recommendation of Chinese
Experimental Animals Administration Legislation. The
mice used in these experiments were 8–12 weeks old.Drug administration
HCT116 cells were grown in culture and then detached
by trypsinization, washed, and resuspended in HBSS.
Next, 0.2 mL of the resuspended cells (1.0 × 106) were
subcutaneously injected into the athymic nude mice to
initiate tumor growth. Tumors were allowed to reach an
average size of 100 mm3, after which mice were random-
ized into 4 groups (n = 10 per group). Mice in group 1
were administered distilled water daily, which served
as a vehicle control. Mice in group 2 were given 5-
fluorouracil (5-FU) intraperitoneally, every 2 days, at a
dosage of 0.5 mg/kg, half the maximum tolerated dose
(MTD) of 5-FU, as previously described [20]. Mice in
groups 3,4 and 5 received YQFS at a daily dose of 200,
400 or 800 mg/kg respectively, by intragastric adminis-
tration for 19 days. In the clinical practice of Chinese
herbal medicine, YQFS is usually prescribed at a daily
dose of 400 mg herbal materials. When this human dose
was converted into an animal dose (at an extraction
yield of 2.5%, for a person weighing 60 kg, and a conver-
sion factor of 12.33 between humans and mice), it was
equivalent to the middle dose (400 mg extract/kg) used
in this study.
Body weight and tumor growth were measured every
2 days. Tumor growth was determined by measuring the
major (L) and minor (W) diameter with a caliper. The
tumor volume was calculated according to the following
formula: tumor volume = π/6 × L ×W2. At the end of ex-
periment, the animals were anesthetized with pentobar-
bital, and the tumor tissue was removed and weighed.
Gelatin zymography of MMP-2/9 activity
All tumor groups were plated onto 12-well culture plates
and made quiescent by incubation in serum-free
DMEM/F-12 for 24 h. The culture medium was col-
lected and centrifuged at 10 000 × g for 5 min at 4°C to
remove cell debris. MMP-2/9 expression was analyzed
as previously described [9]. The gel analysis function in
ImageJ (http://rsbweb.nih.gov/ij/) was used to quantify
protease activity bands by densitometry. Values are
reported in Relative Intensity Units (RIU).
Quantitative RT-PCR analysis
For RNA isolation, tumors were homogenized and
suspended, and RNA was extracted using the RNAspin
Mini Kit (GE Healthcare, Waukesha, WI, USA)
according to the manufacturer’s instructions. For cDNA
synthesis, 1 μg of total RNA was reverse-transcribed
using oligo-dT primers and the Superscript Amplifica-
tion System (Life Technologies, Carlsbad, CA, USA).
Quantitative RT-PCR was carried out using SYBR Green
PCR Master Mix (Life Technologies). The PCR amplifi-
cation program consisted of an initial polymerase activa-
tion at 94°C for 5 min, followed by 35 cycles at 94 C for
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cation of GAPDGH, a relatively invariant internal refer-
ence RNA, was performed in parallel, and cDNA amounts
were standardized to equivalent GAPDGH mRNA levels.
Oligonucleotide primers for VEGF and GAPDGH were as
follows: Oligonucleotide sequence (5’-3’) of ERK1/2
(188 bp), F: 5’-CCTGCTGGACCGGATGTTA-3’, R: 5’-
GTCTCTTGGAAGATCAGCTC-3’, Oligonucleotide se-
quence (5’-3’) of GAPDH (306 bp), F: 5’-ACCCACTCC
TCCACCTTTGA-3’, R: 5’-CTGTTGCTGTAGCCAAAT
TCGT-3’. mRNA expression was determined by real-
time PCR using the TaqMan method as previously de-
scribed [19].
Statistical analysis
All values were expressed as the mean ± S.D. and analyzed
by one-way analysis of variance (ANOVA) followed by
Duncan’s Multiple Range Test using SPSS version 13.0
software; a p-value of less than 0.05 was considered
significant.
Results
Effect of YQFS on the viability of HCT-116 cells
We used a simple and accurate HPLC method for the
simultaneous separation and determination of six compo-
nents to evaluate the quality of YQFS. We then tested
their effects on the growth of the HCT-116 human colo-
rectal cells in vitro. As shown in Figure 1, after treatment
for 24 h, YQFS induced a dose-dependent decrease in
cell viability in HCT-116 cells, as analyzed by MTT assay.
HCT-116 cells showed a significantly reduced rate of
cell growth.Figure 1 Effect of YQFS on the inhibition of HCT-116 cells. Cells
were treated with various concentrations of YQFS and analyzed by
MTT assay. The IC50 value is 34.09 mg/ml. For the dose–response
analysis, we chose three doses below the IC50 value, and turned
into a multiple relationship.Effect of YQFS on apoptosis and cell cycle arrest at
G1- and S-phase in HCT-116 cells
We then tested whether YQFS affected cell cycle pro-
gression. The results showed a significant decrease in
the number of cells in the proliferative G1- and S-phases
and a significant increase in the number of cells in the
G2-phase after 24 h of treatment with YQFS (Figure 2A).
These results indicate cell cycle arrest at the S-phase
after treatment of HCT-116 cells with YQFS. To confirm
these results, we evaluated the effects of YQFS on apop-
tosis in HCT-116 cells. We observed a marked increase
in both early and late stage apoptosis, as assessed by
flow cytometry, in HCT-116 cells after YQFS treatment
compared with control cells (Figure 2A). We then evalu-
ated the effects of YQFS on apoptosis in HCT-116 cells
by using annexin V-FITC and PI staining. Again, we saw
a marked dose-dependent increase in both the early and
late stage apoptosis, as assessed by flow cytometry, in
HCT-116 cells after YQFS treatment, compared with
control cells (Figure 2B).
Effect of YQFS on migration measurement via the wound
healing assay in HCT-116 cells
We examined whether YQFS extract attenuated the mo-
tility of HCT-116 cells using the scratch wound repair
assay. Cell migration increased after 24 h for the control
group, but was substantially reduced when lower dose
YQFS exerts was present (Figure 3). We also tested the
effect of middle and higher dose of YQFS extract, the re-
sult showed a 40%-60% delay in wound closure after
treatment for 24 h (Figure 3). These results suggest that
YQFS inhibited migration/invasion in human colorectal
cancer HCT-116 cells in a dose-dependent manner.
Effect of YQFS on ERK phosphorylation in HCT-116 cells
To determine whether the MAPK pathways are involved
in the anti-invasion and metastasis of tumor progression,
the expression of JNK, ERK and p38 phosphorylation
was examined in HCT-116 cells by western blotting. The
results showed that the ERK signal transduction pathway
was activated in HCT-116 cells. We observed decreased
phosphorylation of ERK (p-ERK) in HCT-116 cells
(Figure 4), but saw no significant effect in the levels of
p-JNK or p-p38 (data not shown) after 24 h of YQFS
treatment. These observations suggest that ERK, but not
JNK or the p38/MAPK pathway, was inhibited by YQFS
thus mediating anti-migration/invasion in human colo-
rectal cancer HCT-116 cells.
Effect of YQFS on tumor growth in colorectal cancer
xenograft mice
In light of our in vitro data on the effect of YQFS in sen-
sitizing colorectal cancer cells, we examined the thera-
peutic potential of YQFS in vivo. Based on our clinical
Figure 2 The Effect of YQFS on apoptosis and the cell cycle in HCT-116 cells. (A) Flow cytometry analysis of the cell cycle distribution of
cultured HCT-116 cells with PI staining following 24 h exposure of cells to YQFS. Detection of apoptosis with Annexin V-FITC/PI binding to HCT-
116 cells. Viable cells (Annexin V−/PI−) are located in the lower left, apoptotic cells (Annexin V+/PI−) in the lower right, post apoptotic secondary
necrotic cells (Annexin V+/PI+) in the upper right and primary necrotic cells (Annexin V−/PI+) in the upper left quadrants, respectively. The
numbers in each quadrant are the percentages of cells in question. (B) Distribution of HCT-116 cells’ cycle indicated by PI staining. The values
shown are the mean ± SEM of 3 experiments. **P < 0.01 vs. the control.
Figure 3 Effect of YQFS on cell migration in a scratch wound repair assay. Scratch-wound motility assays were carried out to detect
wounded monolayers in HCT-116 cells. The effects of various concentrations of YQFS (8 mg/ml, 16 mg/ml and 32 mg/ml) on the migration of
human aortic smooth muscle cells (HASMCs) at 0 h (upper row of images) and 24 h (lower row of images). Cell migration increased in the
control and this effect was attenuated with the addition of YQFS.
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Figure 4 The effect of YQFS on the expression of ERK and
p-ERK in HCT-116 cells. Western blotting assays were carried out
to detect the activation of ERK in HCT-116 cells. HCT-116 cells were
treated with YQFS at 8 mg/ml, 16 mg/ml and 32 mg/ml for 24 h
respectively. Western blotting with was performed with an anti-β
-actin antibody to ensure equal loading of proteins in each lane. The
bolts were photographed and quantitated for each sample and the
data are from three independent experiments.
Figure 5 The effect of YQFS on tumor growth in vivo. After mice
were injected with HCT-116 cells (2 × 107), they were divided into
five groups: Vehicle, L-YQFS (200 mg/kg), M-YQFS (400 mg/kg), and
H-YQFS (800 mg/kg) were administered orally, each day for 18 days.
The 5-Fu group was injected 5-Fluorouracil once every 2 days.
Values were presented as mean ± SD., (n = 10).
Table 1 The effects of YQFS on body- and tumor weight
of experimental animals (means ± SD)
Group Doses
(mg/kg)
n Body weight(g) Tumor
weight(g)Initial Final
Control - 10 20.00 ± 1.00 24.00 ± 1.00 2.29 ± 0.30
L- YQFS 200 10 18.00 ± 1.00 23.00 ± 0.50 1.88 ± 0.14
M- YQFS 400 10 19.00 ± 1.00 23.00 ± 1.00 1.46 ± 0.11*
H- YQFS 800 10 20.00 ± 1.00 24.00 ± 0.50 1.06 ± 0.09**
5-Fu 0.5 10 21.00 ± 1.00 23.40 ± 2.00 0.99 ± 0.08**
*P < 0.05 vs. control; **P < 0.01, vs. control.
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tered 12.33 times the dose given to human patients. Ad-
ministration with herbal mixtures did not cause weight
loss, decreased activity, or changes in fur quality of the
rabbits (data not shown).
The in vivo anti-tumor effect of YQFS was evaluated
by measuring tumor weight and volume in colorectal
cancer xenograft mice, while adverse effects were deter-
mined by measuring any body weight gain. As shown in
Figure 5, H-YQFS treatment resulted in a 51% decrease
in tumor volume compared with the control (997 ±
85 mm3 or 450 ± 49 respectively). Consistent with the
tumor volumes, there was a 54% decrease in the tumor
weights per mouse in the H-YQFS-treated group com-
pared with the control group (1.06 ± 0.09 or 2.29 ± 0.30
grams respectively) as seen in Table 1. These suppressive
effects of YQFS were dose-dependent. However, admin-
istration of different doses of YQFS (L-YQFS, M-YQFS
and H-YQFS) had no effect on body weight gain in ex-
perimental animals (Table 1). Taken together, this sug-
gests that YQFS is potent suppressor of colorectal tumor
growth in vivo, with no apparent signs of toxicity.
Effect of YQFS on apoptosis in colorectal cancer
xenograft mice
To determine whether the inhibitory effect of YQFS on
cancer growth is related to cell proliferation and apop-
tosis, we examined the YQFS pro-apoptotic and anti-
proliferative activities in colorectal cancer mice via im-
munohistochemical (IHC) staining for TUNEL and
PCNA. The data in Figure 6 shows that the apoptotic
index for H-YQFS was 44.24 ± 4.84%, 3.29 times that of
the control (13.45 ± 1.09). These results are in agreementwith our in vitro apoptosis results, which showed that
YQFS significantly induced HCT-116 cell apoptosis in a
dose-dependent manner. These data demonstrated that
YQFS inhibited the proliferation of colorectal cancer
cells and promoted cell apoptosis in vivo.
Effect of YQFS on the expression of MMP-2/9
Based on the preliminary experiments in vitro, we exam-
ined the expression of the angiogenic factors, MMP-2 and
MMP-9, in tumors harvested from the various therapy
groups (Figure 7). Both MMP-2 and MMP-9 expression
was significantly lower in the YQFS-based therapy groups,
suggesting that its antitumor effect may be mediated, in
part, by downregulation of MMP-2/9 expression.
Effect of YQFS on ERK phosphorylation in colorectal
cancer xenograft mice
Based on the preliminary experiments in vitro, we there-
fore examined the effect of YQFS on ERK mRNA levels
in tumor tissue using quantitative RT-PCR. As shown in
Figure 8, YQFS decreased ERK mRNA levels in a dose-
Figure 6 The effect of YQFS on apoptosis in vivo. A TUNEL assay was performed to detect apoptosis in vivo as described in the materials and
methods section. The relative fold increase in apoptosis index is plotted as a graph. Each value is presented as the mean ± SD as determined
from three independent experiments. *P < 0.05 vs. the control group; **P < 0.01 vs. the control group.
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ment resulting in a threefold decrease in ERK mRNA
levels with respect to the control. The results shown are
similar to that of MMP-2/9.
Discussion
In this study, we demonstrated for the first time that
YQFS inhibits tumorigenesis and cancer metastasis in
colorectal cancer both in vitro and in vivo. Our results in-
dicate that YQFS can modulate the ERK/MAPK pathway,
and its downstream factors, by targeting ERK phosphoryl-
ation. We show that the growth of colorectal cancer cellsFigure 7 The Effect of YQFS on the expression of MMP-2/9
in vivo. Gelatin Zymography analysis of MMP-2/9 in vivo, as
described in the materials and methods section. The relative fold
change in expression of MMP-2/9 is plotted as a graph. Each value is
presented as the mean ± SD as determined from three independent
experiments. *P < 0.05 vs. the control; **P < 0.01 vs. the control.is repressed by YQFS-induced apoptosis and inhibition of
migration/invasion. In vivo, YQFS induced a significant
delay in tumor growth, which could be mediated by
decreased expression of MMP-2/9 via the ERK pathway.
Our research therefore suggests that this Chinese Herbal
medicine, YQFS, could inhibit migration/invasion of colo-
rectal cancer by down-regulating MMP-2/9 via inhibition
of the ERK/MAPK signaling pathway. YQFS therefore has
previously undiscovered therapeutic potential for treating
colorectal cancer.
In Asia, the incidence of colorectal cancer has become a
national public health problem [21,22]. Despite advances
in surgical and chemotherapeutic approaches, the resist-
ance of colorectal cancer cells to traditional cytotoxicFigure 8 The effect of YQFS on ERK mRNA levels in vivo. Real-
time quantitative PCR was performed to detect ERK mRNA in vivo.
The data represented here were calculated from the means ± SD
from triplicate experiments. **P < 0.01, vs. the control group.
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most colorectal cancer patients eventually succumbing to
the disease [12]. Therefore, novel therapeutic approaches
for colorectal cancer are needed.
With the use of Traditional Chinese prescriptions and
formulae, which are based on TCM principles, these
agents have been identified as effective anti-cancer drugs
in cancer patients, such as breast carcinoma, gastric can-
cer and colorectal cancer. Our previous clinical studies
have demonstrated that YQFS prolongs the overall sur-
vival for stage IV colorectal cancer patients. It is now
clear that administering herbal extracts may improve
therapeutic outcomes among cancer patients. We there-
fore conducted a series of experiments to examine the
potential mechanisms responsible for the therapeutic ef-
fects of YQFS.
To quantitate the effects of YQFS on cell growth, cell
viability was assayed by reduction of MTT for 24 h with
various concentrations of nimbolide. We found that YQFS
treatment inhibited growth in colorectal cancer HCT-116
cells in a dose-dependent manner (Figure 1). We then
investigated whether YQFS-induced inhibition of cell
growth was due to perturbation of the cell cycle. Cell
phase distribution analysis showed an accumulation of
cells in the S-phase upon treatment withYQFS (Figure 2B),
indicating that YQFS inhibits tumor cell proliferation and
exerts its growth inhibitory actions through alterations in
the cell cycle, and by inducing apoptosis.
It is well accepted that invasion and metastasis are inte-
gral parts of tumor progression and, investigators have
reported that Physalis angulata markedly inhibits migra-
tion and invasion of highly metastatic HSC-3 cells, as
shown by wound-healing repair- and trans-well-assays
[23]. In our study, HCT-116 cell lines showed slower mi-
gration compared with the control after treatment with
YQFS, judged by a scratch-wound motility assay (Figure 3).
These data suggest that YQFS may modulate colorectal
cancer invasion via altered cell motility.
The MAPK pathway represents one of the signaling cas-
cades that link external stimuli to the transcriptional regu-
lation of various molecules including those related to
tumor-invasion and -metastasis. In mammals, three major
MAPK pathways have been identified: extracellular-signal
-regulated kinase (ERK), c-Jun N-terminal kinase (JNK),
and p38 mitogen-activated protein kinase (p38 MAPK)
[24]. There is growing evidence to support a strong correl-
ation between ERK and invasive and metastatic potential
in colorectal cancer [25]. In this study, we found that the
increased levels of phosphorylated ERK1/2 in colorectal
cancer HCT-116 cells were inhibited by YQFS in a dose-
dependent manner. We also found that p38 and JNK1/2
were activated in colorectal cancer HCT-116 cells even
though their activation levels differed. However, YQFS
failed to inhibit phosphorylation of p38 and JNK1/2 inHCT-116 cells suggesting that YQFS might selectively tar-
get the ERK signaling pathway.
To further investigate the general effect of YQFS on
colorectal cancer, we examined the effect of YQFS treat-
ment in vivo. Our results are consistent with previous
in vivo studies, where YQFS inhibited colorectal tumor
growth compared with the control group in a dose-
dependent manner. Furthermore, we found that chronic
treatment with YQFS induced a significant increase in
apoptosis in colorectal tumors, as judged by TUNEL
staining. These results are consistent with studies
performed by Gexia-Zhuyu Tang who showed that HSC
apoptosis was induced via caspase 3 [26].
Within the past few years, many researchers have
demonstrated the importance of MMPs in malignant
transformation. MMP activity has been implicated in
almost every stage of the metastatic cascade from the
primary site to the progression of tumor-extravasation,-
growth and -development. MMPs are enzymes that de-
grade structural components of the extra cellular matrix.
These enzymes regulate a multitude of physiological
processes such as morphogenesis, tissue remodeling and
signaling events. Numerous studies have demonstrated a
strong correlation between MMP-2/9 expression and
migration/invasion in human colorectal cancer cells.
In this study, we found a downregulation in MMP-2/9
expression following exposure to YQFS in rat colorectal
tumors. These results are consistent with previous studies
that evaluated the effects of MMP-2/9 inhibition on the
suppression of tumor migration/invasion [27].
In recent years, there is increasing evidence to support
the role of MMPs in mediating many changes in the
tumor microenvironment during malignant transform-
ation. Importantly, MAP kinase signaling such as ERK,
JNK, p38, plays a significant role in MMP regulation,
particularly MMP-2/9 in tumor cell migration. In this
study, we observed that activation of the ERK pathway
correlated with an increased expression of MMP-2/9.
However, YQFS significantly reduced levels of p-ERK
thus inhibiting the ERK pathway.
YQFS is the standard formulation of Si-Jun-Zi-Tang
with the addition of Rou-dou-kou (Myristica fragrans)
and Ba-yue-zha (Fiveleaf Akebia fruit) to create another
formula known as Yi-Qi-Fu-Sheng-Fang. It was recently
reported that Rou-dou-kou (Myristica fragrans), had a
significant inhibitory effect on the growth of a colorectal
cancer cell line [14]. Furthermore, Ba-yue-zha (Fiveleaf
Akebia fruit), has been shown to remove toxic materials
to inhibit tumor growth, and activate blood circulation
to dissipate blood stasis [15,16], and to improve patients’
survival quality in 60 cases of intermediate and advanced
malignant tumors [28]. In addition, previous studies
have shown that Si-Jun-Zi-Tang can lessen the degree of
post-operational stress and inflammatory response, and
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nutritional therapy [29]. In vivo studies have shown that
SJZD can prevent indomethacin-induced damage of in-
testinal epithelial cells by inhibiting migration and prolif-
eration of IEC-6 cells [30]. These results therefore
strongly support the protective effects of YQFS against
human colorectal cancer.
Conclusions
In conclusion, the present study served to confirm the
antitumor effects of YQFS in vitro and in vivo. Our re-
sults indicate that the therapeutic effect of YQFS may be
explained by the inhibition of ERK-dependent migra-
tion/invasion. In addition, clarification of the underlying
mechanism of YQFS will provide new anti-cancer thera-
peutic targets.
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